The mode of action of anticholinergics in asthma

Reinoud Gosens, Nicholas Gross

Source: Eur Respir J, 52 (4) 1701247; 10.1183/13993003.01247-2017
Journal Issue: October
Disease area: Airway diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Reinoud Gosens, Nicholas Gross. The mode of action of anticholinergics in asthma. Eur Respir J, 52 (4) 1701247; 10.1183/13993003.01247-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
The effect of applying inhaled corticosteroids in treating cough variant asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

Do long-acting β2-adrenoceptor agonists enhance the anti-inflammatory effect of glucocorticoids in asthma?
Source: Eur Respir J 2001; 17: 1059-1061
Year: 2001

Effect of long-acting ß-agonist on bronchodilator response in children with asthma
Source: Eur Respir J, 56 (3) 1902010; 10.1183/13993003.02010-2019
Year: 2020

lnhaled long-acting beta-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults
Source: Eur Respir J 2005; 26: Suppl. 49, 124s
Year: 2005

The effects of addition montelukast to inhaled steroids in the regular treatment of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 262s
Year: 2001

Is it time to move away from short-acting beta-agonists in asthma management?
Source: Eur Respir J, 53 (4) 1802223; 10.1183/13993003.02223-2018
Year: 2019

The effect of combined β2-agonist and anticholinergic inhaled therapy in patients with COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 341s
Year: 2004

Bronchodilator therapies for severe asthma
Source: Eur Respir Mon 2011; 51: 253-267
Year: 2011

Using rates of inhaled long acting beta 2 agonist and corticosteroids in asthma and COPD patients
Source: Eur Respir J 2002; 20: Suppl. 38, 110s
Year: 2002

Persistent local side effects of inhaled corticosteroids in asthmatics; the possible role of GERD
Source: Annual Congress 2008 - Markers and triggers of asthma
Year: 2008

How effective are oral steroids in asthma action plans?
Source: International Congress 2017 – Asthma management
Year: 2017

Effects of inhaled corticosteroids on cough in asthma patients
Source: Eur Respir J 2004; 24: Suppl. 48, 347s
Year: 2004

The effect of inhaled corticosteroids in combination with long-acting beta2-agonists in elite athletes with asthma
Source: Annual Congress 2009 - Asthma and comorbid conditions
Year: 2009

Can long-acting β2 agonists substitute inhaled corticosteroids in stable persistent asthma
Source: Annual Congress 2008 - Improving asthma and anti-allergic therapy
Year: 2008

Antitussive and antiinflammatory effect of montelukast in patients with cough variant asthma
Source: Eur Respir J 2006; 28: Suppl. 50, 440s
Year: 2006

Cough variant asthma treated with bronchodilators, without inhaled corticosteroids
Source: Annual Congress 2009 - From cough to sound analysis of breathing
Year: 2009

The effect of additional use of short-acting beta2 agonist on exercise tolerance in patients with COPD on regular long-acting bronchodilators treatments
Source: International Congress 2015 – New insights into exercise and muscle performance
Year: 2015

Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma
Source: Eur Respir J 2002; 19: 240-245
Year: 2002

The effect on mortality of adding inhaled corticosteroids to long-acting bronchodilators for COPD: A focus on the frequent exacerbator phenotype
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015